Latest filing published 22 Nov 2016 for Tenax Therapeutics, INC., €9,987.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -66.2%Entry US$74,560.00 · Close at T+365 US$25,184.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James P. Mitchum: trading record in brief
James P. Mitchum appears in our data through filings on Tenax Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 2 February 2016 and the latest from 21 November 2016.
Purchases make up the whole of the open-market record (2 purchases, €46k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 22 November 2016, reports a transaction of €9,987 in Tenax Therapeutics, Inc. The latest purchase dates back some time: it was published 3,916 days ago, on 19 February 2016. The median gap between a trade and its publication by SEC (Form 4) is 16 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James P. Mitchum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,000 shares@ US$1.5117.8% of flowcommon stockSEC:0001185945-16-000005:0
- 5,100 shares@ US$2.6822.3% of flowCommon StockSEC:0001354488-16-006306:0Canonical exit: 2 May 2016 (T+90)
- 13,900 shares@ US$2.6560.0% of flowCommon StockSEC:0001354488-16-006306:1Canonical exit: 3 May 2016 (T+90)
3 of 3 declarations
